Agilis strengthens its advisory board

Agilis Biotherapeutics appoints Dr James E Darnell of Rockefeller University to its Scientific Advisory Board


Dr Darnell's scientific research has been recognized by various institutes and universities and has garnered numerous recognitions

Agilis Biotherapeutics has announced the addition of Mr James E Darnell to its Scientific Advisory Board.  Dr Darnell is Vincent Astor Professor Emeritus of the Laboratory of Molecular Cell Biology at the Rockefeller University and a pioneer in RNA research.

Dr Darnell's scientific research has been recognized worldwide by numerous awards and memberships in honorary societies for fundamental discoveries in the molecular biology of mammalian RNA and in cytokine control of transcription. "We are excited to welcome Dr Darnell, an extremely distinguished and accomplished scientist, as a scientific advisor to the company," said Dr Mark Pykett, president and chief executive officer, Agilis. He added, "Dr Darnell brings great experience and expertise that we believe will be immensely valuable to Agilis' research as we optimize our genetic medicines for the treatment of rare diseases."

"I am pleased to join Agilis and hope my experience will aid the quest to transform the treatment of Friedreich's ataxia and other diseases that result from abnormalities in or lack of specific proteins," said Dr Darnell.

Dr Darnell is a member of the American Academy of Arts and Sciences, The American Philosophical Society, the Royal Society, and the Royal Swedish Academy of Sciences. He has received numerous awards, including the National Medal of Science from the White House for lifetime achievement in the field of scientific research.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email